Screener
Vir Biotechnology, Inc. VIR Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s enterprise value?
- Vir Biotechnology, Inc. (VIR) reported enterprise value of $1.52B in Q2 2026.
- How has Vir Biotechnology, Inc.'s enterprise value changed year-over-year?
- Vir Biotechnology, Inc.'s enterprise value increased by 190.6% year-over-year, from $524.47M to $1.52B.
- What is the long-term trend for Vir Biotechnology, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s enterprise value has grown at a -26.0% compound annual growth rate (CAGR), from $3.14B to $695.71M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Vir Biotechnology, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude